IRONWOOD PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 156.02 million shares for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-13.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2020-02-13
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-12-31 was 623.62M shares, a 2.22% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-09-30 was 156.44K shares, a 2.09% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-06-30 was 155.85K shares, a 2.42% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 154.96K shares, a 2.61% increase year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 156.02M shares, a 2.22% increase from fiscal 2018.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 152.63M shares, a 2.44% increase from fiscal 2017.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 148.99M shares, a 2.80% increase from fiscal 2016.
- IRONWOOD PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 144.93M shares, a 1.95% increase from fiscal 2015.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | 623.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 311.89M shares derived: average of 2 quarters · filed 2020-02-13 | 207.98M shares derived: average of 3 quarters · filed 2020-02-13 | 156.02M shares 10-K · filed 2020-02-13 | ||||
| 2019-09-30 | 156.44K shares 10-Q · filed 2019-10-31 | 156.14K shares derived: average of 2 quarters · filed 2019-10-31 | 155.75K shares 10-Q · filed 2019-10-31 | 152.64M shares derived: average of 4 quarters · filed 2020-02-13 | ||||
| 2019-06-30 | 155.85K shares 10-Q · filed 2019-07-30 | 155.41K shares 10-Q · filed 2019-07-30 | 203.46M shares derived: average of 3 quarters · filed 2020-02-13 | 152.64M shares derived: average of 4 quarters · filed 2020-02-13 | ||||
| 2019-03-31 | 154.96K shares 10-Q · filed 2019-05-02 | 305.12M shares derived: average of 2 quarters · filed 2020-02-13 | 203.46M shares derived: average of 3 quarters · filed 2020-02-13 | 152.63M shares derived: average of 4 quarters · filed 2020-02-13 | ||||
| 2018-12-31 | 610.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 305.12M shares derived: average of 2 quarters · filed 2020-02-13 | 203.46M shares derived: average of 3 quarters · filed 2020-02-13 | 152.63M shares 10-K · filed 2020-02-13 | ||||
| 2018-09-30 | 153.23K shares 10-Q · filed 2019-10-31 | 152.69K shares derived: average of 2 quarters · filed 2019-10-31 | 152.14K shares 10-Q · filed 2019-10-31 | 149.00M shares derived: average of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | 152.16K shares 10-Q · filed 2019-07-30 | 151.59K shares 10-Q · filed 2019-07-30 | 198.61M shares derived: average of 3 quarters · filed 2020-02-13 | 148.99M shares derived: average of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | 151.01K shares 10-Q · filed 2019-05-02 | 297.84M shares derived: average of 2 quarters · filed 2020-02-13 | 198.61M shares derived: average of 3 quarters · filed 2020-02-13 | 148.99M shares derived: average of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | 595.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | 297.84M shares derived: average of 2 quarters · filed 2020-02-13 | 198.61M shares derived: average of 3 quarters · filed 2020-02-13 | 148.99M shares 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | 149.50K shares 10-Q · filed 2018-11-06 | 149.14K shares derived: average of 2 quarters · filed 2018-11-06 | 148.69K shares 10-Q · filed 2018-11-06 | 144.93M shares derived: average of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | 148.78K shares 10-Q · filed 2018-08-06 | 148.28K shares 10-Q · filed 2018-08-06 | 193.19M shares derived: average of 3 quarters · filed 2019-02-25 | 144.93M shares derived: average of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | 147.79K shares 10-Q · filed 2018-05-04 | 289.71M shares derived: average of 2 quarters · filed 2019-02-25 | 193.19M shares derived: average of 3 quarters · filed 2019-02-25 | 144.93M shares derived: average of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | 579.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | 289.71M shares derived: average of 2 quarters · filed 2019-02-25 | 193.19M shares derived: average of 3 quarters · filed 2019-02-25 | 144.93M shares 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | 145.18K shares 10-Q · filed 2017-11-02 | 144.91K shares derived: average of 2 quarters · filed 2017-11-02 | 144.47K shares 10-Q · filed 2017-11-02 | 142.16M shares derived: average of 4 quarters · filed 2018-02-22 | ||||
| 2016-06-30 | 144.64K shares 10-Q · filed 2017-08-03 | 144.64M shares 10-Q · filed 2016-08-08 | 144.12K shares 10-Q · filed 2017-08-03 | 144.12M shares 10-Q · filed 2016-08-08 | 189.49M shares derived: average of 3 quarters · filed 2018-02-22 | 142.16M shares derived: average of 4 quarters · filed 2018-02-22 | ||
| 2016-03-31 | 143.59K shares 10-Q · filed 2017-05-08 | 143.59M shares 10-Q · filed 2016-05-10 | 284.17M shares derived: average of 2 quarters · filed 2018-02-22 | 189.49M shares derived: average of 3 quarters · filed 2018-02-22 | 177.64M shares derived: average of 4 quarters · filed 2018-02-22 | |||
| 2015-12-31 | 568.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | 284.17M shares derived: average of 2 quarters · filed 2018-02-22 | 236.81M shares derived: average of 3 quarters · filed 2018-02-22 | 142.16M shares 10-K · filed 2018-02-22 | ||||
| 2015-09-30 | 142.47K shares 10-Q · filed 2016-11-07 | 142.47M shares 10-Q · filed 2015-11-05 | 71.12M shares derived: average of 2 quarters · filed 2016-11-07 | 141.95K shares 10-Q · filed 2016-11-07 | 141.95M shares 10-Q · filed 2015-11-05 | 105.84M shares derived: average of 4 quarters · filed 2017-02-22 | ||
| 2015-06-30 | 142.10M shares 10-Q · filed 2016-08-08 | 141.69M shares 10-Q · filed 2016-08-08 | 141.07M shares derived: average of 3 quarters · filed 2017-02-22 | 140.61M shares derived: average of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | 141.28M shares 10-Q · filed 2016-05-10 | 140.56M shares derived: average of 2 quarters · filed 2017-02-22 | 140.12M shares derived: average of 3 quarters · filed 2017-02-22 | 139.67M shares derived: average of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | 139.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | 139.54M shares derived: average of 2 quarters · filed 2017-02-22 | 139.13M shares derived: average of 3 quarters · filed 2017-02-22 | 136.81M shares 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | 139.23M shares 10-Q · filed 2015-11-05 | 139.23K shares 10-Q · filed 2014-11-05 | 138.77M shares derived: average of 2 quarters · filed 2015-11-05 | 135.80M shares 10-Q · filed 2015-11-05 | 135.80K shares 10-Q · filed 2014-11-05 | 217.59M shares derived: average of 4 quarters · filed 2016-02-19 | ||
| 2014-06-30 | 138.31M shares 10-Q · filed 2015-08-07 | 134.05M shares 10-Q · filed 2015-08-07 | 243.71M shares derived: average of 3 quarters · filed 2016-02-19 | 182.81M shares derived: average of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | 129.75M shares 10-Q · filed 2015-05-06 | 296.41M shares derived: average of 2 quarters · filed 2016-02-19 | 197.64M shares derived: average of 3 quarters · filed 2016-02-19 | 176.59M shares derived: average of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | 463.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | 231.59M shares derived: average of 2 quarters · filed 2016-02-19 | 192.21M shares derived: average of 3 quarters · filed 2016-02-19 | 115.85M shares 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | 120.77K shares 10-Q · filed 2014-11-05 | 56.78M shares derived: average of 2 quarters · filed 2014-11-05 | 114.14K shares 10-Q · filed 2014-11-05 | |||||
| 2013-06-30 | 113.44M shares 10-Q · filed 2014-08-05 | 113.44M shares 10-Q · filed 2013-08-08 | 110.77M shares 10-Q · filed 2014-08-05 | 110.77M shares 10-Q · filed 2013-08-08 | ||||
| 2013-03-31 | 108.07M shares 10-Q · filed 2014-04-29 | 108.07M shares 10-Q · filed 2013-04-23 | ||||||
| 2012-12-31 | 106.40M shares 10-K · filed 2015-02-18 | 106.40M shares 10-K · filed 2013-02-21 | ||||||
| 2012-06-30 | 107.08M shares 10-Q · filed 2013-08-08 | 105.41M shares 10-Q · filed 2013-08-08 | ||||||
| 2012-03-31 | 103.75M shares 10-Q · filed 2013-04-23 | |||||||
| 2011-12-31 | 99.88M shares 10-K · filed 2014-02-07 | 99.87M shares 10-K · filed 2013-02-21 | ||||||
| 2010-12-31 | 89.65M shares 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |